Fatigue, walking, and balance in Charcot-Marie-Tooth disease
This study looks at fatigue and how it affects walking and balance in people with Charcot-Marie-Tooth type 1A. By comparing results with healthy volunteers, researchers hope to better understand fatigue and find ways to help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old.
- You have been diagnosed with Charcot-Marie-Tooth type 1A through a genetic test.
- You can walk at least 200 meters without stopping (with or without a cane or walker).
- You have had a heart check-up (ECG and heart ultrasound) in the last 6 months, or have one scheduled.
- You have not had surgery on your legs or feet in the last year, and do not plan to have surgery during the study.
- You are not pregnant, breastfeeding, or planning to become pregnant in the next 4 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses motion analysis to understand walking and arm function in adults with certain neurological or metabolic diseases. The goal is to find patterns that help doctors better manage these conditions.
This study watches how much you move around at home using a small wearable sensor if you have CMT1A, a genetic nerve condition that affects walking. Researchers want to understand daily activity patterns to better support patients with this condition.
This study examines how autonomic nerves (the nerves that control automatic body functions like heart rate and blood pressure) are affected in people with CMT (Charcot-Marie-Tooth disease), a genetic nerve disorder. Understanding this may help improve treatment and quality of life for CMT patients.
This trial looks for new markers of Charcot-Marie-Tooth 1A (CMT1A) early in the disease. Researchers hope to find signs that can help diagnose and track the disease better, which could lead to better treatments in the future.
This study follows people who have Charcot-Marie-Tooth disease (CMT) and compares them with people without it. It aims to better understand CMT, using both clinical symptoms and genetic test results, which may help future care.
This study is looking for people with Charcot-Marie-Tooth disease (a nerve condition) and healthy volunteers to track long-term changes in the body. Researchers want to see if certain biomarkers (measurable signs) can help predict how CMT progresses over time.
Hear when a new Charcot-Marie-Tooth Type 1A trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.